companydata.dkNEWPHARMA.DK ApS: Financial statements 2013
CVR: 31431824
NEWPHARMA.DK ApS (CVR 31431824) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 1,133,770 and a net result of DKK 1,020,452. That is an increase of 188.4% compared with the year before. Equity amounted to DKK 1,639,292. The solvency ratio was 77.5%.
- Gross Profit
- 1,133,770 kr.
- Profit/Loss
- 1,020,452 kr.
- Equity
- 1,639,292 kr.
- Total Assets
- 2,114,781 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | 1.1 mio. | 1 mio. | 1.6 mio. | - |
| 2012 | - | 393 t. | - | - | - |
Find more companies like NEWPHARMA.DK ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2013
NEWPHARMA.DK ApS has published its annual report for 2012.
About NEWPHARMA.DK ApS
NEWPHARMA.DK ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2008 and dissolved in 2015. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. In 2013, the company reported a gross profit of DKK 1,133,770 and a net result of DKK 1,020,452. Equity amounted to DKK 1,639,292.